Micro Aftermath Archived

ImmunityBio FDA warning letter

Activity declining — narrative losing relevance.

Score
0.3
Velocity
▲ 0.0
Articles
5
Sources
2

Top Movers

TickerSectorChange
IBRX
Healthcare-0.1%

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Apr 07, 2026
Why ImmunityBio Stock Slumped on Monday Neutral
Mar 31, 2026
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in … Neutral
Mar 25, 2026
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for … Neutral
Mar 24, 2026
Why ImmunityBio Stock Is Down More Than 20% Today Neutral

Related Articles

Why ImmunityBio Stock Slumped on Monday

Nasdaq · Apr 07, 2026
Mixed

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC

Yahoo Finance · Mar 25, 2026
Mixed

Why ImmunityBio Stock Is Down More Than 20% Today

Yahoo Finance · Mar 24, 2026
Bearish

Timeline

First SeenMar 24, 2026
Last UpdatedMar 24, 2026